The Cooper Companies, Inc. $COO Shares Bought by Franklin Resources Inc.

Franklin Resources Inc. grew its position in The Cooper Companies, Inc. (NASDAQ:COO) by 108.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,022,033 shares of the medical device company’s stock after acquiring an additional 2,089,763 shares during the period. Franklin Resources Inc.’s holdings in Cooper Companies were worth $329,646,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Brandywine Global Investment Management LLC acquired a new position in Cooper Companies during the 4th quarter worth approximately $3,584,000. Manchester Capital Management LLC lifted its holdings in shares of Cooper Companies by 34.0% in the 4th quarter. Manchester Capital Management LLC now owns 1,666 shares of the medical device company’s stock valued at $137,000 after buying an additional 423 shares during the period. Capital International Inc. CA boosted its stake in shares of Cooper Companies by 22.9% in the fourth quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company’s stock valued at $9,688,000 after buying an additional 22,054 shares in the last quarter. Los Angeles Capital Management LLC acquired a new position in Cooper Companies during the fourth quarter worth $75,000. Finally, Havemeyer Place LP acquired a new position in Cooper Companies during the fourth quarter worth $2,429,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Citigroup reissued a “neutral” rating and issued a $69.00 target price (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. BNP Paribas Exane reduced their price objective on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday. Stifel Nicolaus lowered their target price on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday. Finally, Rothschild & Co Redburn cut shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a report on Wednesday, March 4th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $82.64.

Cooper Companies Price Performance

COO stock opened at $66.79 on Tuesday. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock’s 50 day moving average price is $64.99 and its 200 day moving average price is $74.50. The firm has a market cap of $13.03 billion, a P/E ratio of 56.60, a PEG ratio of 1.73 and a beta of 0.88.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter last year, the business posted $0.96 earnings per share. Cooper Companies’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.